Norfloxacin



Indications and Reactions:

Role Indications Reactions
Primary
Urinary Tract Infection 28.9%
Hypertension 7.9%
Skin Test 7.9%
Type 2 Diabetes Mellitus 7.9%
Diabetes Mellitus 5.3%
Paraesthesia 5.3%
Product Used For Unknown Indication 5.3%
Allergy Test 2.6%
Androgenetic Alopecia 2.6%
Asthma 2.6%
Cholangitis 2.6%
Constipation 2.6%
Cystitis 2.6%
Depression 2.6%
Glioblastoma 2.6%
Gout 2.6%
Overgrowth Bacterial 2.6%
Pyrexia 2.6%
Sjogren's Syndrome 2.6%
Cytolytic Hepatitis 12.5%
Convulsion 6.3%
Hypertension 6.3%
Insulinoma 6.3%
Muscular Weakness 6.3%
Poor Quality Sleep 6.3%
Premature Baby 6.3%
Premature Labour 6.3%
Rash Morbilliform 6.3%
Skin Test Positive 6.3%
Syncope 6.3%
Thrombocytopenia 6.3%
Tinnitus 6.3%
Type Iii Immune Complex Mediated Reaction 6.3%
Urosepsis 6.3%
Secondary
Product Used For Unknown Indication 21.1%
Urinary Tract Infection 9.7%
Drug Use For Unknown Indication 7.9%
Respiratory Tract Infection 7.0%
Arthritis Infective 6.9%
Gastrointestinal Infection 6.9%
Genitourinary Tract Infection 6.9%
Osteomyelitis 6.9%
Skin Infection 6.9%
Diarrhoea 3.8%
Hypertension 3.6%
Hypercholesterolaemia 2.3%
Drug Exposure During Pregnancy 1.5%
B-cell Lymphoma 1.3%
Dental Care 1.3%
Depression 1.3%
Lymphoma 1.3%
Atrial Fibrillation 1.1%
Non-small Cell Lung Cancer 1.1%
Prophylaxis 1.1%
Rhabdomyolysis 22.5%
Renal Failure Acute 11.3%
Toxic Epidermal Necrolysis 7.5%
Urinary Tract Infection 7.5%
Convulsion 5.0%
Rash Erythematous 5.0%
Thrombocytopenia 5.0%
Weight Decreased 5.0%
Haematemesis 3.8%
Chest Pain 2.5%
Dermatitis Allergic 2.5%
Drug Interaction 2.5%
Duodenal Ulcer 2.5%
Episcleritis 2.5%
Hallucination 2.5%
Hepatic Function Abnormal 2.5%
Hyponatraemia 2.5%
Macrocytosis 2.5%
Neuropathy 2.5%
Paraesthesia 2.5%
Concomitant
Product Used For Unknown Indication 18.7%
Drug Use For Unknown Indication 15.8%
Hepatic Neoplasm Malignant 10.1%
Prophylaxis 8.9%
Abdominal Pain Upper 7.1%
Disbacteriosis 4.6%
Rheumatoid Arthritis 4.5%
Nausea 4.0%
Diagnostic Procedure 3.9%
Urinary Tract Infection 3.5%
Infection Prophylaxis 2.7%
Hypertension 2.6%
Haemorrhage Prophylaxis 2.3%
Vomiting 2.1%
Back Pain 1.8%
Bone Marrow Conditioning Regimen 1.6%
Renal Transplant 1.5%
Acute Myeloid Leukaemia 1.5%
Multiple Sclerosis 1.5%
Hiv Infection 1.3%
Vomiting 11.5%
Hepatic Encephalopathy 8.9%
Staphylococcal Infection 8.9%
Urinary Tract Infection 8.9%
Glomerulonephritis Membranous 8.3%
Death 5.7%
Rhabdomyolysis 5.7%
Transient Ischaemic Attack 5.7%
Swollen Tongue 4.7%
Tremor 4.2%
Disseminated Intravascular Coagulation 3.1%
Thrombocytopenia 3.1%
Urticaria 3.1%
Alveolitis Allergic 2.6%
Colitis Ischaemic 2.6%
Enterobacter Infection 2.6%
Lower Gastrointestinal Haemorrhage 2.6%
Pyrexia 2.6%
Upper Gastrointestinal Haemorrhage 2.6%
Ureteric Obstruction 2.6%
Interacting
Drug Use For Unknown Indication 21.6%
Cystitis 16.2%
Urinary Tract Infection 13.5%
Atrial Fibrillation 8.1%
Hepatic Cirrhosis 5.4%
Product Used For Unknown Indication 5.4%
Stem Cell Transplant 5.4%
Viral Infection 5.4%
Epilepsy 2.7%
Gout 2.7%
Hypercholesterolaemia 2.7%
Hyperlipidaemia 2.7%
Hypertension 2.7%
Meningioma 2.7%
Neuropathy Peripheral 2.7%
Drug Interaction 46.7%
Convulsion 6.7%
Electrocardiogram Qt Prolonged 6.7%
Muscle Necrosis 6.7%
Prothrombin Time Prolonged 6.7%
Rhabdomyolysis 6.7%
Sinus Bradycardia 6.7%
Urinary Tract Infection 6.7%
Venoocclusive Liver Disease 6.7%